D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 17,055 185 World Ranking 15408 National Ranking 7984

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His scientific interests lie mostly in AL amyloidosis, Amyloidosis, Internal medicine, Cancer research and Gastroenterology. His AL amyloidosis course of study focuses on Chemotherapy and Immunoglobulin Light-chain Amyloidosis. His work focuses on many connections between Amyloidosis and other disciplines, such as Immunology, that overlap with his field of interest in Clinical research and Clinical trial.

Internal medicine is closely attributed to Surgery in his research. His Gastroenterology research includes elements of Tolerability, Survival analysis and Thalidomide. As a part of the same scientific study, David C. Seldin usually deals with the Melphalan, concentrating on Autologous stem-cell transplantation and frequently concerns with Plasma cell dyscrasia.

His most cited work include:

  • High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study (523 citations)
  • Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial (386 citations)
  • Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. (351 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are AL amyloidosis, Internal medicine, Amyloidosis, Surgery and Melphalan. The various areas that David C. Seldin examines in his AL amyloidosis study include Plasma cell dyscrasia and Autologous stem-cell transplantation, Transplantation. His studies in Transplantation integrate themes in fields like Hematology and Stem cell.

His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Oncology and Cardiology. His Amyloidosis study which covers Immunoglobulin light chain that intersects with Molecular biology. David C. Seldin has researched Melphalan in several fields, including Bortezomib and Nitrogen mustard.

He most often published in these fields:

  • AL amyloidosis (56.62%)
  • Internal medicine (44.37%)
  • Amyloidosis (46.36%)

What were the highlights of his more recent work (between 2013-2020)?

  • Internal medicine (44.37%)
  • AL amyloidosis (56.62%)
  • Amyloidosis (46.36%)

In recent papers he was focusing on the following fields of study:

David C. Seldin spends much of his time researching Internal medicine, AL amyloidosis, Amyloidosis, Surgery and Pathology. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Oncology and Cardiology. His research integrates issues of Bortezomib, Tolerability and Melphalan, Transplantation in his study of AL amyloidosis.

His study focuses on the intersection of Transplantation and fields such as Stem cell with connections in the field of Signal transduction, Cancer research and Aryl hydrocarbon receptor. His Amyloidosis study integrates concerns from other disciplines, such as Heart failure, Survival rate, Transthyretin, Immunoglobulin light chain and Amyloid. In general Pathology study, his work on Biopsy often relates to the realm of Organ dysfunction, thereby connecting several areas of interest.

Between 2013 and 2020, his most popular works were:

  • Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study. (130 citations)
  • First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction (120 citations)
  • Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain‐mediated cardiotoxicity (84 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

His primary areas of investigation include Amyloidosis, Internal medicine, AL amyloidosis, Pathology and Surgery. The concepts of his Amyloidosis study are interwoven with issues in Immunoglobulin light chain, Cardiomyopathy, Transthyretin and Disease. David C. Seldin interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine.

His AL amyloidosis research incorporates themes from Tolerability, Weakness and Melphalan. His Surgery research integrates issues from Cardiac amyloidosis and Cardiology. His research investigates the link between Amyloid cardiomyopathy and topics such as Cell biology that cross with problems in Amyloid and Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

Martha Skinner;Vaishali Sanchorawala;David C Seldin;Laura M Dember.
Annals of Internal Medicine (2004)

796 Citations

Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle.

David C. Seldin;Philip Leder.
Science (1995)

540 Citations

Amyloidosis: Pathogenesis and New Therapeutic Options

Giampaolo Merlini;David C. Seldin;David C. Seldin;David C. Seldin;Morie A. Gertz.
Journal of Clinical Oncology (2011)

508 Citations

Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial

John L. Berk;Ole B. Suhr;Laura Obici;Yoshiki Sekijima.
JAMA (2013)

503 Citations

Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit.

Xin Xu;Paul A. Toselli;Lonnie D. Russell;David C. Seldin.
Nature Genetics (1999)

466 Citations

Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan.

E Razin;J N Ihle;D Seldin;J M Mencia-Huerta.
Journal of Immunology (1984)

443 Citations

Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells.

L B Schwartz;R A Lewis;D Seldin;K F Austen.
Journal of Immunology (1981)

428 Citations

Protein kinase CK2 in mammary gland tumorigenesis.

Esther Landesman-Bollag;Raphaëlle Romieu-Mourez;Diane H Song;Gail E Sonenshein.
Oncogene (2001)

420 Citations

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion

Dan Yang;Ying Zhang;Hao G. Nguyen;Milka Koupenova.
Journal of Clinical Investigation (2006)

360 Citations

Tal‐1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.

M. A. Kelliher;D. C. Seldin;P. Leder.
The EMBO Journal (1996)

345 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David C. Seldin

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 181

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 180

Giampaolo Merlini

Giampaolo Merlini

University of Pavia

Publications: 159

Nelson Leung

Nelson Leung

Mayo Clinic

Publications: 104

Martha Q. Lacy

Martha Q. Lacy

Mayo Clinic

Publications: 103

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 100

Francis K. Buadi

Francis K. Buadi

Mayo Clinic

Publications: 88

Suzanne R. Hayman

Suzanne R. Hayman

Mayo Clinic

Publications: 85

Richard L. Stevens

Richard L. Stevens

Brigham and Women's Hospital

Publications: 76

Julian D. Gillmore

Julian D. Gillmore

University College London

Publications: 75

Lorenzo A. Pinna

Lorenzo A. Pinna

University of Padua

Publications: 73

Robert A. Kyle

Robert A. Kyle

Mayo Clinic

Publications: 69

David Dingli

David Dingli

Mayo Clinic

Publications: 68

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 63

Helen J. Lachmann

Helen J. Lachmann

University College London

Publications: 61

Mathew S. Maurer

Mathew S. Maurer

Columbia University

Publications: 57

Something went wrong. Please try again later.